Cerus reported $-13.51M in EBITDA for its fiscal quarter ending in March of 2023.





Ebitda Change Date
GRIFOLS EUR 473M 120M Jun/2026
Haemonetics USD 111.41M 15.25M Sep/2026
Neogen USD 41.6M 3.8M Jun/2026
OraSure Technologies USD -17.7M 4.06M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Quidel USD 148M 18.7M Sep/2026
STAAR Surgical USD 14.36M 5.64M Sep/2026
Terumo JPY 116.67B 58.79B Jun/2026